Combination chemotherapy with gemcitabine plus oxaliplatin in patients with refractory germ cell cancer
Phase 2
- Conditions
- germ cell cancer
- Registration Number
- JPRN-UMIN000017471
- Lead Sponsor
- Department of Urology, Tohoku University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1.patient with symptomatic interstitial pneumonia 2.patient with grade 3 or 4 cardiac insufficiency with NYHA classification 3.patient with severe infection 4.patient with severe comorbidity 5.patient with severe allergy 6.patient with active another malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rate
- Secondary Outcome Measures
Name Time Method median survival time, progression free survival